Yüklüyor......

HER2-Positive Breast Cancer: Current Management of Early, Advanced, and Recurrent Disease

PURPOSE OF REVIEW: This review describes the current treatment of human epidermal growth factor receptor-2 (HER2) positive breast cancer with a focus on recently reported clinical trials. Treatment of resistant disease and central nervous system metastases will be reviewed as will new agents that ar...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Opin Obstet Gynecol
Asıl Yazarlar: Callahan, Rena, Hurvitz, Sara
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307801/
https://ncbi.nlm.nih.gov/pubmed/21500375
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!